Journal of Enzyme Inhibition and Medicinal Chemistry · 2022 · 13 citations · 13 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMolecular OncologyCancer MetabolismHypoxia AdaptationOncology PharmacologyAnticancer ActivityAnticancer Mechanism Of ActionAntiproliferative AgentsAntiproliferative Drug ActionCancer Cell Proliferation InhibitionCarbonic Anhydrase FunctionCarbonic Anhydrase InhibitorsLewis Acidity
Carbonic anhydrases (EC 4.2.1.1) catalyse the reversible hydration of CO2 into bicarbonate and protons. As a hypoxia-sensitive and tumour-associated isoform, isoform CA IX, is significantly overexpressed in various malignancies, being a validated target for new anticancer/antimetastatic drugs. A multitude of studies has shown that CA IX inhibition decreases cancer cell proliferation and metastasis through pHe/pHi modulation and enhancement of ferroptosis among others. Numerous studies demonstrated increased efficacy of cytotoxic drugs combined with CA inhibitors (CAIs) in various cancer types. We tested the inhibitory effect of boric acid (BA), an inorganic Lewis acid, on CA IX as well as other isoforms (CA I, II, and XII). BA acted as a millimolar in vitro CAI, decreased proliferation of two cancer cell lines, although not strong correlations between the in vitro inhibition and in vivo effects were observed. The mechanism of antiproliferative action of BA should be investigated in more detail.
13
Emerging role of carbonic anhydrase inhibitors
Claudiu T. Supuran · Clinical Science · 2021 · 194 citations
Boric acid inhibits human prostate cancer cell proliferation
Wade T. Barranco, Curtis D. Eckhert · Cancer Letters · 2004 · 175 citations
Medicine, Oncology, Pharmacology +6
Dietary boron intake and prostate cancer risk
Yan Cui, Meiko Winton, Zuo‐Feng Zhang et al. · Oncology Reports · 2004 · 146 citations